Wall Street likes wobble on health reform
With the stunning victory of Republican Scott Brown in the Massachusetts election for U.S. Senate, Wall Street analysts
expect to see a "run" on health care stocks.
Public Companies
Articles
Fortune Industries names new chief executive
Fortune Industries Inc., an Indianapolis-based professional employer organization, has appointed Tena Mayberry as its CEO.
Mayberry, who also will continue to serve as president, succeeds John Fisbeck.
With utilities under pressure, shareholders unite
The Indiana Utility Shareholders Association aims to be the “collective voice” of investors
in four of the big utilities operating in Indiana.
National animal-welfare group targets Steak n Shake
The Humane Society of the United States bought $2,000 worth of Steak n Shake stock this week in hopes of getting the company
to work with food producers that use humane farming methods.
Stericycle to expand in Indianapolis
Illinois-based medical waste disposal firm Stericycle Inc. will expand its Indianapolis operations, creating as many as 109
jobs by 2011, the Indiana Economic Development Corp. announced Wednesday.
Hillenbrand acquiring conveyor manufacturer
The Batesville holding company said it will purchase K-Tron International Inc. in New Jersey for about $435 million, including
$45 million in K-Tron debt and cash on hand. The deal is expected to close by the end of March.
Emmis 3Q revenue declines, but company still posts profit
Indianapolis-based Emmis Communications Corp. reported lower revenue during its fiscal third quarter, but still managed a
small profit.
Emmis sees third-quarter revenue decline
Indianapolis-based Emmis Communications Corp.’s revenue dropped, but the radio and publishing company still posted a profit
during its third fiscal quarter.
PROXY CORNER: Zimmer Holdings Inc.
Zimmer Holdings Inc. develops, manufactures
and markets orthopedic and dental reconstructive implants, spinal implants, trauma products and other related surgical products.
Steak n Shake slashes restaurant spending as CEO hoards cash
From 1999 to 2008, Steak n Shake Co. spent an average of $55 million a year to add dozens of restaurants and buy equipment
for existing
ones. In 2009, the locally based
chain spent just $5.8 million.
Omnicity continues wireless broadband acquisition spree
Omnicity makes seventh acquisition since going public in February. The Rushville company aims to be nation’s largest wireless
broadband provider in rural markets.
PROXY CORNER: Duke Realty Corp.
Duke Realty Corp. is a real estate investment trust that develops, manages and owns industrial, office and retail properties across the Midwest and Southeast.
Insurance company rejects Steak n Shake takeover bid
A small Michigan insurer has rejected an acquisition bid from The Steak n Shake Co., describing the offer as a “hostile takeover
attempt.”
Cash-flush Finish Line likely to open new stores
With an improved balance sheet and $150 million in its pocket, the athletic-gear retailer is looking at new locations and
improving its online shopping hub.
Finish Line profit exceeds analyst expectations
The Finish Line Inc. barely eked into the black in its fiscal third quarter, but even that exceeded analysts’ expectations.
Conseco raises nearly $223 million in stock offering
The Carmel-based life and health insurer immediately applied $161 million of the funds to its bank loans.
UPDATE: Steak n Shake turning away from core business
The Steak n Shake Co. is taking a dramatic turn away from its core business with a bid to purchase a Michigan insurer in a
deal valued at almost $37 million.
BREAKING: Steak n Shake offers to acquire Michigan insurer
The Steak n Shake Co. has offered to acquire all of the outstanding shares of Fremont Michigan Insuracorp Inc. in a deal
that could be worth almost $37 million.
Smulyan signs new contract to lead Emmis
Jeff Smulyan agrees to terms on a new three-year contract to lead Emmis. Signing and performance bonuses could lead to big
pay raise.
Lilly pays $90 million for autoimmune drug
By acquiring an experimental medicine for rheumatoid arthritis, the Indianapolis-based drugmaker is increasing its focus on autoimmune
diseases.